The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback